Inergetics Adds NFL Prospect Dwight Bentley to Team Surgex

Paramus, NJ-based nutritional supplement developer Inergetics, Inc. (OTCBB: NRTI) said that Dwight “Bill” Bentley, a cornerback from Louisiana-Lafayette, signed an endorsement contract to represent the Surgex™ product line.  Bentley is currently projected to go in the third or fourth round of the NFL Draft and the 108th overall best player in the upcoming NFL Draft that starts this week.

Inergetics CEO Mark Mirken commented, “We know Bill will represent our Surgex™ brand well and be a great ambassador for Inergetics in his new NFL home.  We are excited to have him join our team and wish him good luck in this week’s NFL Draft!”

In a Inergetics statement, Bentley said, “With so many supplements available, it’s so valuable to find one that actually does what it claims to do.  Surgex™ has helped my endurance and recovery as those are key parts of playing in the NFL.  Part of my preparation for the NFL combine and draft includes maintaining my weight during training.  The Surgex™ Ready to Drink product will allow my muscle and fat percentages to be in perfect balance.”

Bentley’s career numbers for the Ragin Cajuns of Louisiana Lafayette include 232 tackles, 13 for a loss, 1.5 sacks, 7 interceptions and 20 passes broken up.  Bentley returned 2 interceptions for touchdowns in 2011 which was his senior year.  Bentley also earned All Sun-Belt Conference honors 2 times during his collegiate career.  Bentley garnered national attention in high school at Florida’s Pahokee High where he won three state championships.

Shares of Inergetics looked like they were running a 4.3, 40-yard dash in January and February; sprinting from around 12 cents all the way up to 55.7 cents.  Shares have since cooled, sliding back to hold a higher-low in the area of 18 cents currently.  Bentley may help give the company some fuel in the tank again to help bolster its market cap upwards from current levels of $6.26 million.

Inergetics (NRTI) Stock Quote and News:

Disclaimer: Neither nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at


Add your comment

Commenting is allowed only for registered users.

Other articlesgo to homepage

Dig-It Underground Stock Chart Analysis Video

Dig-It Underground Stock Chart Analysis Video(0)

A spike in volume and rise in share price has Dig-It Underground (Pink Sheets: DIGX) on the radar for more movement in the morning. A thinly-traded stock, volatility has been strong in the chart as the MACD trends upwards towards zero as the chart is making a bounce off the bottom. The Relative Strength Index

GelTech Receives First Order for FireIce from Turkey

GelTech Receives First Order for FireIce from Turkey(0)

GelTech Solutions, Inc. (OTCBB: GLTC) this morning reported receipt of the first order from Turkey through partner Nano Girisim Ltd. Sti.  Nano Girism Ltd. Sti., a distributor of industrial products based in Istanbul.  Nano Girisim intends to initially promote GelTech’s FireIce, a revolutionary water enhancing fire suppressant for use in fire extinguishers, as Turkish law

Lyris to Host Third Quarter Earnings Webcast

Lyris to Host Third Quarter Earnings Webcast(0)

Global digital marketing company Lyris, Inc. (OTCBB:LYRI) will report its operating results for the third quarter of fiscal 2012 on Thursday, May 10. The company will hold a conference call and webcast to discuss its financial results and operating activities open to all interested parties at 8 a.m., Pacific Daylight Time (11 a.m., Eastern Daylight

Athersys Meets with FDA to Discuss Suppressing GvHD in Leukemia and other Cancers

Athersys Meets with FDA to Discuss Suppressing GvHD in Leukemia and other Cancers(0)

Graft versus Host Disease (GvHD) is an area of great unmet medical that represents a significant risk to cancer patients throughout the world.  The condition occurs when patients receive a bone marrow transplant following radiation and/or chemotherapy, and the transplanted immune cells begin to attack the patient, causing significant pain and disability, or even death.

Judge Denies Taylor Armstrong’s Request to Dismiss Case with, Damages Could Grow in Excess of $3 Million

Judge Denies Taylor Armstrong’s Request to Dismiss Case with, Damages Could Grow in Excess of $3 Million(0)

In the latest round of the litigation between MMRGlobal, Inc. (OTCBB: MMRF) company (“MMR”) and Beverly Hills Housewife Taylor Armstrong, Los Angeles Superior Court Judge Frederick Shaller dealt a blow to Taylor Armstrong in denying her motion for a summary judgment to have the lawsuit against her dismissed. We first broke the story

read more

Stay Informed

Receive the OTCS Newsletter *


* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

© 2011 Viper Enterprises, LLC. All rights reserved.